Unilife Corporation

All Photos Twitter.com
Pleased to enter strategic collaboration with Amgen inc license agreement, development & supply, up to $75MM prn.to/1QbKYCn
The special meeting that was scheduled for Monday, Feb 8, 4PM ET at the Crowne Plaza, KOP is cancelled.bit.ly/1STCdgV
Flex Medical VP Bill Partridge says “wearaputics” can use non-medical innovations to improve compliance at #DDP2016
Retweeted by Unilife Corporation
Future therapies will unit drug, device & data to contain, monitor, deliver & talk $UNIS bit.ly/1S4fRsK
"In this new healthcare age a key rule is gaining traction-the drug with the best data wins" bit.ly/1S4fRsK
Check out a great article on how devices, drugs and data are converging for better health outcomes for all bit.ly/1S4fRsK
Unilife Signs Commercial Supply Agreement with MedImmune prn.to/1ksnThT $UNIS Long-term wearable injector supply for late-stage mAb
A great read on wearable technology and how it's set to disrupt healthcare. bit.ly/1LWMS99
Wearable injectors will help redefine many therapy areas this decade, reducing cost and improving patient care bit.ly/1NHUsF1
Imperium: A New Prefilled Insulin Patch Pump healthline.com/diabetesmine/u… via @Healthline
Unilife Introduces World’s First Instant Patch Pump for Insulin. MedGadget. bit.ly/1My8FTc
Imperium combines therapeutic advantages of pumps with low cost and convenience of pens bit.ly/1DbKfgd
Introducing Imperium, the world's first instant patch pump for insulin. bit.ly/1eB7rZx
Why are pharma companies seeking preferred partners for injectable drug delivery? OnDrug Delivery. bit.ly/1G0tDsS #unilife $unis
$UNIS Q3 FY’15 earnings call happening now. Stream online now at ir.unilife.com/events.cfm
$UNIS issues Q3 FY’15 update – available at ir.unilife.com. Investor Conference Call begins @ 4:30pm ET
A great breakfast put on by @PennsylvaniaBio this morning with a strong turnout of biotech and life-sci leaders. #CEOPanel @BIOConvention
New #Unilife CMO is a BC ophthalmologist with +20yrs as exec. and consultancy at pharma, biotech and med. device cos bit.ly/1JolR9P
New CMO’s experience at pharma and drug delivery device companies amplify Unilife’s customer-centric business focus bit.ly/1JolR9P
Unilife is pleased to announce the appointment of Richard L. Beckman, M.D. as its Chief Medical Officer bit.ly/1JolR9P
Smart devices can redefine the treatment of a range of chronic therapies where compliance is sub-optimal. bit.ly/1AKUJOP
Our latest blog on why smart-tech devices can optimize value-based healthcare outcomes bit.ly/1AKUJOP $UNIS
Looking forward to Pharmapack in Paris next week Feb 11-12. Our team will be at booth 304. Schedule a meeting. bit.ly/16HVwGj $UNIS
Unilife is pleased to welcome David Hastings as CFO. bit.ly/1DAyvCr $UNIS
LISA. The One and Only. Smart Reusable Injector. Now with Bluetooth connectivity. $UNIS. bit.ly/1sahFGI
Long-Term Commercial Supply Agreement for Use of Depot-jectwith Approved Ocular Injection Drug:ir.unilife.com
$UNIS #unilife Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors with Sanofi.
Unilife’s expansion of manufacturing capacity for wearable injectors is in response to accelerating customer demand bit.ly/1p4j0Xj
Unilife had 12 active programs spanning all 6 product platforms with multiple add’l programs continuing to commence bit.ly/1p4j0Xj
$UNIS will continue the commercial rollout of multiple Unifill products to customers under current and new agreements bit.ly/1p4j0Xj
$UNIS upfront investments in R&D is a leading indicator of future agreements and customer relationships bit.ly/1p4j0Xj
Unilife team is now more than 210 strong, with 80% of staff in product development, customer programs & manufacturing bit.ly/1p4j0Xj
Unilife CEO: Company has reached a critical mass in product range and expertise. Expects to moderate R&D during FY’15 bit.ly/1p4j0Xj
$UNIS directing R&D to specific unmet or emerging market needs of current and future customers bit.ly/1p4j0Xj
$UNIS reports FY’14 increase in rev of $12MM to $14.7MM; increase of cash receipts of $22.5MM to $23.7MM vs. FY’13 bit.ly/1p4j0Xj
Latest #unilife article out in Drug Development and Delivery. bit.ly/Xf6HRW $UNIS
$UNIS Revenue for full year 2014 anticipated to be at the high end of the $12 million to $15 million guidance range: bit.ly/1pr0vQ4
Video of the new Unifill Finesse manufacturing line available: bit.ly/1qLDBXt
#Unilife remains on schedule to commence the commercial sales of Unifill between now & the middle of FY2015. bit.ly/1pr0vQ4
Read #Unilife's latest press release to learn about the outlook of FY2014 and what we anticipate for FY2015: bit.ly/1pr0vQ4
#Unilife accelerates investments in Manufacturing and R&D to meet increasing demand from pharma & biotech companies bit.ly/1pr0vQ4
A few design enhancements made to our Unilife website homepage at unilife.com $UNIS @unilife
Read this landmark industry article by Unilife on wearable injectors in OnDrug Delivery bit.ly/1pfjZnJ $UNIS
Strategic alliances between drug & device makers helping to enhance & differentiate therapies bit.ly/1nNyvW4
Drug and device manufacturers are aligning their respective strengths to enhance injectable therapies: bit.ly/1yel0E8
Unilife CEO opinion piece out today on how to generate value from drug-device strategic partnerships. bit.ly/1nNyvW4
Unilife generating cash receipts at 3/31/14 from 10 ongoing customer programs per Q3 FY’14 conf. call bit.ly/1jkuN0l
The chiller to supply large volume air flow to our new cleanrooms has been installed on the roof $UNIS #unilife
As part of our clean room expansion in York, air-handlers are this week being installed on our roof $UNIS #unilife
Unilife CEO 3Q CC: “… clear pathway to profitability based on existing supply agreements" bit.ly/1jkuN0l
Twiends™ uses the Twitter™ API, displays it's logo & trademarks, and is not endorsed or certified by them. These items remain the property of Twitter. We do not sell followers, we only provide display advertising. Bots & fake accounts are not permitted on twiends. © 2009
Grow Your Twitter Free
Want To Grow Your Twitter?
We help other people find and follow you on Twitter.
Key Info:
Started in 2009
Over 6 million signups
Country targeting provided
We never auto tweet to your timeline
We never auto follow others
We actively moderate our community
Please Share
Please upgrade your browser  chrome